Disease and steroid burden in IBD
Dr Christian Selinger from St James University Hospital, UK, reviews the role of steroids in IBD in 2022 – the good the bad and the ugly! A/Prof. Peter De Cruz then takes us through effective steroid tapering in IBD, including risk stratification, how to use steroid responsiveness as a guide to induction intensity and how to wean patients off them. The presenters then discuss their points in the context of an Australian case study.
Strategies to target Mucosal Healing in IBD
Prof. James Lindsay from the Royal London Hospital, UK, shares his views on how to work towards achieving mucosal healing in the clinic. Then he and A/Prof. Britt Christensen discuss the treatment decisions involved in an Australian case study of a women diagnosed with ulcerative colitis and her journey through drug intolerances, flares and pregnancy.
Investigating treatment de-escalation strategies in Crohn’s Disease
In this episode, A/Prof John Ding takes us through the SPARE study, part of the Biocycle Project – a European Union funded project designed to assess long-term treatment strategies in Crohn’s Disease. And we get to listen to the questions that Dr Emily Wright had for A/Prof Ding about the study during their review of ECCO 2022.
ABBV-AU-00098-MC August 2022.
Copyright © 2022 AbbVie Pty Ltd. Mascot NSW 2020 Australia.
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates.
No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.